-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 ErrVoHO0ahjwf9dL3qMXrcJdT3rUUaDxBGg6hcISW7R2hRd9BeAcRmkkCYlgDgld
 IbGQe+ySBLVk4drjvVvvOw==

<SEC-DOCUMENT>0001005477-04-001933.txt : 20040513
<SEC-HEADER>0001005477-04-001933.hdr.sgml : 20040513
<ACCEPTANCE-DATETIME>20040513145412
ACCESSION NUMBER:		0001005477-04-001933
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20040512
FILED AS OF DATE:		20040513

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANTARES PHARMA  INC
		CENTRAL INDEX KEY:			0001016169
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				411350192
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		707 EAGLEVIEW BOULEVARD
		STREET 2:		SUITE 414
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341
		BUSINESS PHONE:		610-458-6200

	MAIL ADDRESS:	
		STREET 1:		707 EAGLEVIEW BOULEVARD
		STREET 2:		SUITE 414
		CITY:			EXTON
		STATE:			PA
		ZIP:			19341

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANTARES PHARMA INC /MN/
		DATE OF NAME CHANGE:	20010604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MEDI JECT CORP /MN/
		DATE OF NAME CHANGE:	19960605

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			XMARK ASSET MANAGEMENT LLC
		CENTRAL INDEX KEY:			0001118481
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20945
		FILM NUMBER:		04802552

	BUSINESS ADDRESS:	
		STREET 1:		CARNEGIE HALL TOWER
		STREET 2:		152 W 57TH ST 21ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2122478200

	MAIL ADDRESS:	
		STREET 1:		CARNEGIE HALL TOWER
		STREET 2:		152 W 57TH ST 21ST FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER NAME:	
		FORMER CONFORMED NAME:	BROWN SIMPSON ASSET MANAGEMENT LLC
		DATE OF NAME CHANGE:	20000707
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar123.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2004-05-12</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001016169</issuerCik>
        <issuerName>ANTARES PHARMA  INC</issuerName>
        <issuerTradingSymbol>ANTR.OB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001118481</rptOwnerCik>
            <rptOwnerName>XMARK ASSET MANAGEMENT LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>152 W 57TH STREET, 21ST FLOOR</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10019</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, par value $0.01 per share</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <transactionDate>
                <value>2004-05-13</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>210000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>1.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3031243</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnotes 2 through 8</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The reporting person is Xmark Asset Management, LLC, (&quot;XAM&quot;), a New York limited liability company.  XAM's interest in the securities reported herein is limited to its pecuniary interest, if any, in Xmark Fund, L.P., a Delaware limited partnership (&quot;Xmark LP&quot;), and Xmark Fund, Ltd., a Cayman Islands exempted company (&quot;Xmark Ltd&quot;).</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Mitchell D. Kaye, Manager of Xmark Asset Management, LLC</signatureName>
        <signatureDate>2004-05-13</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----